You are here
CONFLUENCE LIFE SCIENCES, INC.
http://confluencelifesciences.com
UEI: N/A
# of Employees: 32
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
ITK TXK Inhibitors as Oral Immunotherapeutic Drugs for Psoriasis
Amount: $225,000.00Psoriasis is a devastating autoimmune disease that manifests itself in the form of patchy inflammatory skin lesions that can appear anywhere throughout the body resulting in tremendous physical pain a ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
ITK inhibitors as an immunotherapeutic approach to colorectal cancer
Amount: $299,949.00Colorectal cancer CRC is the third most common form of cancer resulting in over half a million deaths each year Despite the use of chemotherapies and biologics the five year CRC survival rate is ...
SBIRPhase I2016Department of Health and Human Services National Institutes of Health -
Development of TAK1 Compounds for Neonatal Onset Multisystem Inflammatory Disease
Amount: $224,850.00DESCRIPTION (provided by applicant): Cryopyrin-associated periodic syndromes (CAPS) are a family of rare autoinflammatory diseases of which neonatal-onset multisystem inflammatory disease (NOMID) is t ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Monodispersed magnetic nanoparticles for improved diagnostic imaging. Phase II: S
Amount: $289,278.00DESCRIPTION (provided by applicant): Pancreatic cancer (PC) is the fourth leading cause of death from cancer in the US. Treatment options for this disease are extremely limited and prognosis is poor. ...
SBIRPhase I2013Department of Health and Human Services National Institutes of Health
